Business
Spotify raising prices for Canadian subscribers. What to know
|
|
Spotify is raising prices for its subscription plans across several countries, including Canada.
The move will result in a $1 price increase for a number of plans, including the premium individual plan, which will increase to $10.99 a month, the family plan to $16.99 and the student plan to $5.99. Spotify’s duo plan has increased by $2 to $14.99 a month.
Previously, the price for the individual plan was $9.99 per month, $12.99 for duo, $15.99 for family and $4.99 for students.
Spotify said in a news release Monday that the “market landscape” has continued to evolve since it launched in 2008.
In an email to some customers, Spotify said it’s raising prices “so that we can continue to invest in and innovate on our product offerings and features, and bring you the best experience.”
Spotify has moved in recent months to boost margins with hundreds of layoffs and a restructuring of the podcast unit, which it had built up with billions in investment.
The price increases come at a time when streaming services, both audio and video, are under rising investor pressure to boost profitability after years of prioritizing user growth.
Rivals Apple, Amazon and Tidal have all increased prices this year, while YouTube also hiked prices last week on its monthly and annual premium plans in the U.S. for the first time since the subscription service launched in 2018.
Spotify, which had indicated in April that it would raise prices in 2023, also raised prices in 46 countries last year.
Shares of the Sweden-based company were down Tuesday morning after it reported a bigger-than-expected loss and missed revenue estimates for its second quarter.
— with files from Reuters
We use cookies and data to
- Deliver and maintain Google services
- Track outages and protect against spam, fraud, and abuse
- Measure audience engagement and site statistics to understand how our services are used and enhance the quality of those services
If you choose to “Accept all,” we will also use cookies and data to
- Develop and improve new services
- Deliver and measure the effectiveness of ads
- Show personalized content, depending on your settings
- Show personalized ads, depending on your settings
If you choose to “Reject all,” we will not use cookies for these additional purposes.
Non-personalized content is influenced by things like the content you’re currently viewing, activity in your active Search session, and your location. Non-personalized ads are influenced by the content you’re currently viewing and your general location. Personalized content and ads can also include more relevant results, recommendations, and tailored ads based on past activity from this browser, like previous Google searches. We also use cookies and data to tailor the experience to be age-appropriate, if relevant.
Select “More options” to see additional information, including details about managing your privacy settings. You can also visit g.co/privacytools at any time.
|
|
Health Canada has given its stamp of approval to Pfizer-BioNTech Comirnaty’s new COVID-19 vaccine that targets the Omicron XBB.1.5 subvariant.
The health department says it received Pfizer-BioNTech’s submission on June 29, 2023 and decided to authorize the shot’s use for individuals aged six months and older after “a thorough and independent review of the evidence.”
Health Canada says the vaccine is authorized as a one-dose vaccine for individuals five years of age and older, regardless of their COVID-19 vaccination history.
Infants and children between six months and less than five years of age, who have not previously received a complete COVID-19 primary series, should receive three doses. If they have completed a primary series, officials say they should receive one dose.
Moderna’s COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant was authorized(opens in a new tab) by Health Canada earlier this month.
The department says it’s currently reviewing a submission from Novavax for its COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for people 12 years of age and older.
The National Advisory Committee on Immunization (NACI) is anticipated to provide guidance on the rollout of the newly approved COVID-19 vaccines in the coming months.
“Canada will have ample supply of the new formulation of mRNA vaccines available in fall 2023,” Health Canada said in a news release Thursday.
“Vaccination continues to be one of the most effective ways to protect ourselves against COVID-19. Evidence indicates that vaccines approved for use in Canada are effective at preventing severe illness, hospitalization and death from COVID-19.”
|
|
Hyundai and Kia are recalling more than 600,000 vehicles in Canada and millions more in the U.S. due to a problem with the anti-lock braking system that can start a fire.
Documents posted by U.S. safety regulators on Wednesday say the anti-lock brake control module can leak fluid and cause an electrical short. That can touch off a fire while the vehicles are parked or being driven.
Hyundai says 326,942 vehicles in Canada are impacted, including:
- 77,571 model year 2012-2015 Hyundai Accent vehicles
- 153,026 model year 2011-2015 Hyundai Elantra vehicles;
- 4,403 model year 2013-2015 Hyundai Elantra Coupe vehicles;
- 85 model year 2014-2015 Hyundai Equus vehicles;
- 7,789 model year 2011-2015 Hyundai Genesis Coupe vehicles;
- 8,507 model year 2013-2015 Hyundai Santa Fe vehicles;
- 24,795 model year 2013 Hyundai Santa Fe Sport vehicles;
- 46,318 model year 2010-2013 Hyundai Tucson vehicles;
- 4,448 model year 2010-2012 Hyundai Veracruz vehicles.
An additional 1,642,551 of those and other makes and models are being recalled in the U.S.
The company says it is aware of 21 fires linked to the default in the United States, as well as 22 “thermal incidents,” including visible smoke, burning and melting, but Hyundai Canada told CBC News in a statement that there are “no crashes, injuries, or fatalities attributable to this condition.”
Kia Canada says 276,225 vehicles in Canada are impacted, including:
- 2010-2011 Borregos;
- 2015-2016 Cadenzas;
- 2010-2013 Fortes;
- 2010-2013 Forte Koups;
- 2015 K900s;
- 2010-2015 Optimas;
- 2012-2017 Rios;
- 2010-2017 Rondos,
- 2011-2014 Sorrentos;
- 2011-2013 Souls;
- 2010 Sportages;
An additional 1.7 million Kias in the U.S. are included in the recall.
In a statement, the U.S. National Highway Traffic Safety Administration said that “until these recalled vehicles have been repaired … the safest place to park them is outside and away from homes and other structures.”
It said that “fires can occur whether the vehicle is parked and turned off or while driving.”
Dealers will replace the anti-lock brake fuse at no cost to owners, but owners won’t be notified by mail until November.
Fast Rising British Artist Danny Fox on the Five Artists Inspiring Him Right Now – Artsy
American anxiety, Georgian fireworks and a Black British pioneer – the week in art – The Guardian
China Economy Improved Further in September, Satellite Data Show – Bloomberg
-
Economy23 hours ago
Fed’s Goolsbee Says Traditional Economic View May Cause Overshoot
-
Business22 hours ago
‘We are not there yet’: Metrolinx refuses to give end date for long-overdue Eglinton Crosstown LRT
-
Economy22 hours ago
German Economy to Shrink 0.6% in 2023 Before Wages Drive Rebound
-
Art13 hours ago
Details of the Pokémon/Van Gogh art museum crossover are just as adorable as we’d hoped【Pics】
-
News15 hours ago
Canadian immigration consultant’s plan to open India office paused due to political turmoil
-
Business21 hours ago
Alberta sets Canadian record for annual net interprovincial population growth: StatCan
-
News20 hours ago
What are Canada’s most popular baby names?
-
Art16 hours ago
Scalpers Are Ruining A Pokémon Art Exhibit